Downloaded from 3
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Gut Microbiota and Inflammation
International Journal of Environmental Research and Public Health Review The Gut Microbiota and Inflammation: An Overview 1, 2 1, 1, , Zahraa Al Bander *, Marloes Dekker Nitert , Aya Mousa y and Negar Naderpoor * y 1 Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne 3168, Australia; [email protected] 2 School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane 4072, Australia; [email protected] * Correspondence: [email protected] (Z.A.B.); [email protected] (N.N.); Tel.: +61-38-572-2896 (N.N.) These authors contributed equally to this work. y Received: 10 September 2020; Accepted: 15 October 2020; Published: 19 October 2020 Abstract: The gut microbiota encompasses a diverse community of bacteria that carry out various functions influencing the overall health of the host. These comprise nutrient metabolism, immune system regulation and natural defence against infection. The presence of certain bacteria is associated with inflammatory molecules that may bring about inflammation in various body tissues. Inflammation underlies many chronic multisystem conditions including obesity, atherosclerosis, type 2 diabetes mellitus and inflammatory bowel disease. Inflammation may be triggered by structural components of the bacteria which can result in a cascade of inflammatory pathways involving interleukins and other cytokines. Similarly, by-products of metabolic processes in bacteria, including some short-chain fatty acids, can play a role in inhibiting inflammatory processes. In this review, we aimed to provide an overview of the relationship between the gut microbiota and inflammatory molecules and to highlight relevant knowledge gaps in this field. -
Human Microbiome: Your Body Is an Ecosystem
Human Microbiome: Your Body Is an Ecosystem This StepRead is based on an article provided by the American Museum of Natural History. What Is an Ecosystem? An ecosystem is a community of living things. The living things in an ecosystem interact with each other and with the non-living things around them. One example of an ecosystem is a forest. Every forest has a mix of living things, like plants and animals, and non-living things, like air, sunlight, rocks, and water. The mix of living and non-living things in each forest is unique. It is different from the mix of living and non-living things in any other ecosystem. You Are an Ecosystem The human body is also an ecosystem. There are trillions tiny organisms living in and on it. These organisms are known as microbes and include bacteria, viruses, and fungi. There are more of them living on just your skin right now than there are people on Earth. And there are a thousand times more than that in your gut! All the microbes in and on the human body form communities. The human body is an ecosystem. It is home to trillions of microbes. These communities are part of the ecosystem of the human Photo Credit: Gaby D’Alessandro/AMNH body. Together, all of these communities are known as the human microbiome. No two human microbiomes are the same. Because of this, you are a unique ecosystem. There is no other ecosystem like your body. Humans & Microbes Microbes have been around for more than 3.5 billion years. -
THE HUMAN MICROBIOTA: the ROLE of MICROBIAL COMMUNITIES in HEALTH and DISEASE La Microbiota Humana: Comunidades Microbianas En La Salud Y En La Enfermedad
ACTA BIOLÓGICA COLOMBIANA http://www.revistas.unal.edu.co/index.php/actabiol SEDE BOGOTÁ FACULTAD DE CIENCIAS ARTÍCULODEPARTAMENTO DE DE REVISIÓN BIOLOGÍA INVITADO / INVITED REVIEW THE HUMAN MICROBIOTA: THE ROLE OF MICROBIAL COMMUNITIES IN HEALTH AND DISEASE La microbiota humana: comunidades microbianas en la salud y en la enfermedad Luz Elena BOTERO1,2, Luisa DELGADO-SERRANO3,4, Martha Lucía CEPEDA HERNÁNDEZ3, Patricia DEL PORTILLO OBANDO3, María Mercedes ZAMBRANO EDER3. 1 Facultad de Medicina, Universidad Pontificia Bolivariana. Calle 78B no. 72A-109, Bloque B, Piso 5. Medellín, Colombia. 2 Unidad de Bacteriología y Micobacterias, Corporación para Investigaciones Biológicas, Unidad Pontificia Bolivariana. Carrera 72A no. 78B-141. Medellín, Colombia. 3 Corporación Corpogen. Carrera 5 no. 66A-34. Bogotá D.C., Colombia. 4 Centro de Bioinformática y Biología Computacional- BIOS. Carrera 15B no. 161. Manizales, Colombia. For correspondence. [email protected] Received: 22nd March 2015, Returned for revision: 14th April 2015, Accepted: 10th July 2015. Associate Editor: Nubia Estela Matta Camacho. Citation / Citar este artículo como: Botero LE, Delgado-Serrano L, Cepeda ML, Del Portillo P, Zambrano MM. The human microbiota: the role of microbial communities in health and disease. Acta biol. Colomb. 2016;21(1):5-15. doi: http://dx.doi.org/10.15446/abc.v21n1.49761 ABSTRACT During the last decade, there has been increasing awareness of the massive number of microorganisms, collectively known as the human microbiota, that are associated with humans. This microbiota outnumbers the host cells by approximately a factor of ten and contains a large repertoire of microbial genome-encoded metabolic processes. The diverse human microbiota and its associated metabolic potential can provide the host with novel functions that can influence host health and disease status in ways that still need to be analyzed. -
From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation
diseases Review From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation Carole Nicco 1 , Armelle Paule 2, Peter Konturek 3 and Marvin Edeas 1,* 1 Cochin Institute, INSERM U1016, University Paris Descartes, Development, Reproduction and Cancer, Cochin Hospital, 75014 Paris, France; [email protected] 2 International Society of Microbiota, 75002 Paris, France; [email protected] 3 Teaching Hospital of the University of Jena, Thuringia-Clinic Saalfeld, 07318 Saalfeld, Germany; [email protected] * Correspondence: [email protected] Received: 6 March 2020; Accepted: 10 April 2020; Published: 15 April 2020 Abstract: Fecal Microbiota Transplantation (FMT) is suggested as an efficacious therapeutic strategy for restoring intestinal microbial balance, and thus for treating disease associated with alteration of gut microbiota. FMT consists of the administration of fresh or frozen fecal microorganisms from a healthy donor into the intestinal tract of diseased patients. At this time, in according to healthcare authorities, FMT is mainly used to treat recurrent Clostridium difficile. Despite the existence of a few existing stool banks worldwide and many studies of the FMT, there is no standard method for producing material for FMT, and there are a multitude of factors that can vary between the institutions. The main constraints for the therapeutic uses of FMT are safety concerns and acceptability. Technical and logistical issues arise when establishing such a non-standardized treatment into clinical practice with safety and proper governance. In this context, our manuscript describes a process of donor safety screening for FMT compiling clinical and biological examinations, questionnaires and interviews of donors. -
Oral Microbiota Features in Subjects with Down Syndrome and Periodontal Diseases: a Systematic Review
International Journal of Molecular Sciences Review Oral Microbiota Features in Subjects with Down Syndrome and Periodontal Diseases: A Systematic Review Maria Contaldo 1,* , Alberta Lucchese 1, Antonio Romano 1 , Fedora Della Vella 2 , Dario Di Stasio 1 , Rosario Serpico 1 and Massimo Petruzzi 2 1 Multidisciplinary Department of Medical-Surgical and Dental Specialties, University of Campania Luigi Vanvitelli, Via Luigi de Crecchio, 6, 80138 Naples, Italy; [email protected] (A.L.); [email protected] (A.R.); [email protected] (D.D.S.); [email protected] (R.S.) 2 Interdisciplinary Department of Medicine, University of Bari “Aldo Moro”, 70121 Bari, Italy; [email protected] (F.D.V.); [email protected] (M.P.) * Correspondence: [email protected] or [email protected]; Tel.: +39-3204876058 Abstract: Down syndrome (DS) is a genetic disorder associated with early-onset periodontitis and other periodontal diseases (PDs). The present work aimed to systematically review the scientific literature reporting studies in vivo on oral microbiota features in subjects with DS and related periodontal health and to highlight any correlation and difference with subjects not affected by DS, with and without PDs. PubMed, Web of Science, Scopus and Cochrane were searched for relevant studies in May 2021. The participants were subjects affected by Down syndrome (DS) with and without periodontal diseases; the study compared subjects with periodontal diseases but not affected by DS, and DS without periodontal diseases; the outcomes were the differences in oral microbiota/periodontopathogen bacterial composition among subjects considered; the study Citation: Contaldo, M.; Lucchese, A.; design was a systematic review. -
Human Microbiota Network: Unveiling Potential Crosstalk Between the Different Microbiota Ecosystems and Their Role in Health and Disease
nutrients Review Human Microbiota Network: Unveiling Potential Crosstalk between the Different Microbiota Ecosystems and Their Role in Health and Disease Jose E. Martínez †, Augusto Vargas † , Tania Pérez-Sánchez , Ignacio J. Encío , Miriam Cabello-Olmo * and Miguel Barajas * Biochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain; [email protected] (J.E.M.); [email protected] (A.V.); [email protected] (T.P.-S.); [email protected] (I.J.E.) * Correspondence: [email protected] (M.C.-O.); [email protected] (M.B.) † These authors contributed equally to this work. Abstract: The human body is host to a large number of microorganisms which conform the human microbiota, that is known to play an important role in health and disease. Although most of the microorganisms that coexist with us are located in the gut, microbial cells present in other locations (like skin, respiratory tract, genitourinary tract, and the vaginal zone in women) also play a significant role regulating host health. The fact that there are different kinds of microbiota in different body areas does not mean they are independent. It is plausible that connection exist, and different studies have shown that the microbiota present in different zones of the human body has the capability of communicating through secondary metabolites. In this sense, dysbiosis in one body compartment Citation: Martínez, J.E.; Vargas, A.; may negatively affect distal areas and contribute to the development of diseases. Accordingly, it Pérez-Sánchez, T.; Encío, I.J.; could be hypothesized that the whole set of microbial cells that inhabit the human body form a Cabello-Olmo, M.; Barajas, M. -
The Human Gut Microbiota: a Dynamic Interplay with the Host from Birth to Senescence Settled During Childhood
Review nature publishing group The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood Lorenza Putignani1, Federica Del Chierico2, Andrea Petrucca2,3, Pamela Vernocchi2,4 and Bruno Dallapiccola5 The microbiota “organ” is the central bioreactor of the gastroin- producing immunological memory (2). Indeed, the intestinal testinal tract, populated by a total of 1014 bacteria and charac- epithelium at the interface between microbiota and lymphoid terized by a genomic content (microbiome), which represents tissue plays a crucial role in the mucosa immune response more than 100 times the human genome. The microbiota (2). The IS ability to coevolve with the microbiota during the plays an important role in child health by acting as a barrier perinatal life allows the host and the microbiota to coexist in a against pathogens and their invasion with a highly dynamic relationship of mutual benefit, which consists in dispensing, in modality, exerting metabolic multistep functions and stimu- a highly coordinated way, specific immune responses toward lating the development of the host immune system, through the biomass of foreign antigens, and in discriminating false well-organized programming, which influences all of the alarms triggered by benign antigens (2). The failure to obtain growth and aging processes. The advent of “omics” technolo- or maintain this complex homeostasis has a negative impact gies (genomics, proteomics, metabolomics), characterized by on the intestinal and systemic health (2). Once the balance complex technological platforms and advanced analytical and fails, the “disturbance” causes the disease, triggering an abnor- computational procedures, has opened new avenues to the mal inflammatory response as it happens, for example, for the knowledge of the gut microbiota ecosystem, clarifying some inflammatory bowel diseases in newborns (2). -
Prevotella Intermedia
The principles of identification of oral anaerobic pathogens Dr. Edit Urbán © by author Department of Clinical Microbiology, Faculty of Medicine ESCMID Online University of Lecture Szeged, Hungary Library Oral Microbiological Ecology Portrait of Antonie van Leeuwenhoek (1632–1723) by Jan Verkolje Leeuwenhook in 1683-realized, that the film accumulated on the surface of the teeth contained diverse structural elements: bacteria Several hundred of different© bacteria,by author fungi and protozoans can live in the oral cavity When these organisms adhere to some surface they form an organizedESCMID mass called Online dental plaque Lecture or biofilm Library © by author ESCMID Online Lecture Library Gram-negative anaerobes Non-motile rods: Motile rods: Bacteriodaceae Selenomonas Prevotella Wolinella/Campylobacter Porphyromonas Treponema Bacteroides Mitsuokella Cocci: Veillonella Fusobacterium Leptotrichia © byCapnophyles: author Haemophilus A. actinomycetemcomitans ESCMID Online C. hominis, Lecture Eikenella Library Capnocytophaga Gram-positive anaerobes Rods: Cocci: Actinomyces Stomatococcus Propionibacterium Gemella Lactobacillus Peptostreptococcus Bifidobacterium Eubacterium Clostridium © by author Facultative: Streptococcus Rothia dentocariosa Micrococcus ESCMIDCorynebacterium Online LectureStaphylococcus Library © by author ESCMID Online Lecture Library Microbiology of periodontal disease The periodontium consist of gingiva, periodontial ligament, root cementerum and alveolar bone Bacteria cause virtually all forms of inflammatory -
Identification and Antimicrobial Susceptibility Testing of Anaerobic
antibiotics Review Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik’s Cube of Clinical Microbiology? Márió Gajdács 1,*, Gabriella Spengler 1 and Edit Urbán 2 1 Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, 6720 Szeged, Hungary; [email protected] 2 Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged, 6725 Szeged, Hungary; [email protected] * Correspondence: [email protected]; Tel.: +36-62-342-843 Academic Editor: Leonard Amaral Received: 28 September 2017; Accepted: 3 November 2017; Published: 7 November 2017 Abstract: Anaerobic bacteria have pivotal roles in the microbiota of humans and they are significant infectious agents involved in many pathological processes, both in immunocompetent and immunocompromised individuals. Their isolation, cultivation and correct identification differs significantly from the workup of aerobic species, although the use of new technologies (e.g., matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, whole genome sequencing) changed anaerobic diagnostics dramatically. In the past, antimicrobial susceptibility of these microorganisms showed predictable patterns and empirical therapy could be safely administered but recently a steady and clear increase in the resistance for several important drugs (β-lactams, clindamycin) has been observed worldwide. For this reason, antimicrobial susceptibility testing of anaerobic isolates for surveillance -
Oral Microbiota Identifies Patients in Early Onset Rheumatoid Arthritis
microorganisms Article Oral Microbiota Identifies Patients in Early Onset Rheumatoid Arthritis Anders Esberg 1,* , Linda Johansson 2, Ingegerd Johansson 1 and Solbritt Rantapää Dahlqvist 2,* 1 Department of Odontology, Umeå University, 901 87 Umeå, Sweden; [email protected] 2 Department of Public Health and Medicine, Rheumatology, Umeå University, 901 87 Umeå, Sweden; [email protected] * Correspondence: [email protected] (A.E.); [email protected] (S.R.D.) Abstract: Rheumatoid arthritis (RA) is the most common autoimmune inflammatory disease, and single periodontitis-associated bacteria have been suggested in disease manifestation. Here, the oral microbiota was characterized in relation to the early onset of RA (eRA) taking periodontal status into consideration. 16S rRNA gene amplicon sequencing of saliva bacterial DNA from 61 eRA patients without disease-modifying anti-rheumatic drugs and 59 matched controls was performed. Taxonomic classification at 98.5% was conducted against the Human Oral Microbiome Database, microbiota functions were predicted using PICRUSt, and periodontal status linked from the Swedish quality reg- ister for clinically assessed caries and periodontitis. The participants were classified into three distinct microbiota-based cluster groups with cluster allocation differences by eRA status. Independently of periodontal status, eRA patients had enriched levels of Prevotella pleuritidis, Treponema denticola, Porphyromonas endodontalis and Filifactor alocis species and in the Porphyromonas and Fusobacterium genera and functions linked to ornithine metabolism, glucosylceramidase, beta-lactamase resistance, biphenyl degradation, fatty acid metabolism and 17-beta-estradiol-17-dehydrogenase metabolism. Citation: Esberg, A.; Johansson, L.; The results support a deviating oral microbiota composition already in eRA patients compared with Johansson, I.; Dahlqvist, S.R. -
Alteration of Salivary Microbiome in Periodontitis with Or Without Type-2 Diabetes Mellitus and Metformin Treatment
www.nature.com/scientificreports OPEN Alteration of salivary microbiome in periodontitis with or without type‑2 diabetes mellitus and metformin treatment Xiaoyu Sun1,2,3, Meihui Li1,2, Li Xia4, Zhaohui Fang5, Shenjun Yu3, Jike Gao3, Qiang Feng1,2* & Pishan Yang1,6* We aimed to explore the efects of type‑2 diabetes mellitus (T2DM) and hypoglycemic therapy on the salivary microbiome in periodontitis patients and identify the potential salivary micro‑biomarker for the early warning of T2DM. Saliva samples were collected from healthy individuals (Health), periodontitis patients (P), T2DM patients, periodontitis patients with T2DM (DAP), and DAP patients treated with Metformin (Met). Samples were determined by16S rRNA gene sequencing. 29 phyla, 322 genera, and 333 species of salivary microbiome were annotated. Compared to the Health group, the P and DAP group showed a signifcantly higher diversity of saliva microbiota, while the T2DM and Met group had no signifcant diference in microbial abundance but showed a trend of increasing diversity. Other than well‑known periodontitis‑inducing pathogens, the proportion of Prevotella copri, Alloprevotella rava, and Ralstonia pickettii, etc. were also signifcantly increased in periodontitis patients with or without T2DM. After efective glycemic control, the abundance of Prevotella copri, Alloprevotella rava, Ralstonia pickettii, etc. decreased in periodontitis patients with companion T2DM. The accuracies of the classifcation models in diferentiating Health‑vs.‑P, DAP‑vs.‑P, and T2DM‑vs.‑P were 100%, 96.3%, and 98.1%, respectively. Hypoglycemic therapy could reconstruct the saliva microbiota and hence improve the localized conditions of diabetes patients with periodontitis. Periodontitis is one of the most frequent bacteria-induced infammatory diseases in the oral cavity. -
Exploring the Connection Between Porphyromonas Gingivalis
biomolecules Article Exploring the Connection between Porphyromonas gingivalis and Neurodegenerative Diseases: A Pilot Quantitative Study on the Bacterium Abundance in Oral Cavity and the Amount of Antibodies in Serum Raffaella Franciotti 1 , Pamela Pignatelli 2 , Claudia Carrarini 1, Federica Maria Romei 2, Martina Mastrippolito 2, Antonella Gentile 2, Rosa Mancinelli 1, Stefania Fulle 1 , Adriano Piattelli 2,3,4, Marco Onofrj 1 and Maria Cristina Curia 2,* 1 Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, 66013 Chieti, Italy; [email protected] (R.F.); [email protected] (C.C.); [email protected] (R.M.); [email protected] (S.F.); [email protected] (M.O.) 2 Department of Medical, Oral and Biotechnological Sciences, “G. d’Annunzio” University of Chieti-Pescara, 66013 Chieti, Italy; [email protected] (P.P.); [email protected] (F.M.R.); [email protected] (M.M.); [email protected] (A.G.); [email protected] (A.P.) 3 Fondazione Villa Serena per la Ricerca, Città S. Angelo, 65013 Pescara, Italy 4 Casa di Cura “Villa Serena” del Dott. L. Petruzzi, Città S. Angelo, 65013 Pescara, Italy * Correspondence: [email protected] Citation: Franciotti, R.; Pignatelli, P.; Abstract: Recent studies support the hypothesis that microbes can seed some Alzheimer’s disease Carrarini, C.; Romei, F.M.; Mastrippolito, M.; Gentile, A.; (AD) cases, leading to inflammation and overproduction of amyloid peptides. Porphyromonas gin- Mancinelli, R.; Fulle, S.; Piattelli, A.; givalis (Pg) is a keystone pathogen of chronic periodontitis and has been identified as risk factor Onofrj, M.; et al.